S. G. Kim

发表

Selective allosteric enhancement of agonist binding and function at human A3 adenosine receptors by a series of imidazoquinoline derivatives.

Adriaan P IJzerman, Kenneth A Jacobson, K. Jacobson, 2002, Molecular pharmacology.

Engineering of A3 adenosine and P2Y nucleotide receptors and their ligands

K. Jacobson, Zhang-Guo Gao, D. Barak, 2003, Drug development research.

p53-Independent induction of Fas and apoptosis in leukemic cells by an adenosine derivative, Cl-IB-MECA.

K. Jacobson, C. Hoffmann, Yun-jin Jung, 2002, Biochemical pharmacology.

P2Y6 Nucleotide Receptor Activates PKC to Protect 1321N1 Astrocytoma Cells Against Tumor Necrosis Factor-Induced Apoptosis

K. Jacobson, Zhang-Guo Gao, C. Brodie, 2003, Cellular and Molecular Neurobiology.

Tumor necrosis factor alpha-induced apoptosis in astrocytes is prevented by the activation of P2Y6, but not P2Y4 nucleotide receptors.

K. Jacobson, Zhang-Guo Gao, T. Chang, 2003, Biochemical pharmacology.

Structural Determinants of A3 Adenosine Receptor Activation: Nucleoside Ligands at the Agonist/Antagonist Boundary

Kenneth A. Jacobson, Carl R. Johnson, Dov Barak, 2002 .

Structural determinants of A(3) adenosine receptor activation: nucleoside ligands at the agonist/antagonist boundary.

Carl R. Johnson, Dov Barak, Kenneth A Jacobson, 2002, Journal of medicinal chemistry.

Differential allosteric modulation by amiloride analogues of agonist and antagonist binding at A(1) and A(3) adenosine receptors.

K. Jacobson, A. IJzerman, C. Müller, 2003, Biochemical Pharmacology.

Roles of BCL-2 and caspase 3 in the adenosine A3 receptor-induced apoptosis

K. Jacobson, C. Brodie, E. Appel, 2001, Journal of Molecular Neuroscience.